GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » EPS without NRI

Veradigm (Veradigm) EPS without NRI

: $1.19 (TTM As of Sep. 2022)
View and export this data going back to 1999. Start your Free Trial

Veradigm's earnings per share without non-recurring items for the three months ended in Sep. 2022 was $0.23. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2022 was $1.19.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Veradigm's EPS without NRI or its related term are showing as below:

MDRX's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 9.1
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Veradigm's EPS (Diluted) for the three months ended in Sep. 2022 was $0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was $0.41.

Veradigm's EPS (Basic) for the three months ended in Sep. 2022 was $0.13. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2022 was $0.50.


Veradigm EPS without NRI Historical Data

The historical data trend for Veradigm's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veradigm Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.56 -1.24 -0.40 0.99

Veradigm Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.79 0.14 0.03 0.23

Competitive Comparison

For the Health Information Services subindustry, Veradigm's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veradigm PE Ratio without NRI Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Veradigm's PE Ratio without NRI falls into.



Veradigm EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veradigm  (OTCPK:MDRX) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Veradigm EPS without NRI Related Terms

Thank you for viewing the detailed overview of Veradigm's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Veradigm (Veradigm) Business Description

Traded in Other Exchanges
N/A
Address
222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
Executives
Shih Yin Ho director 222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez director C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton officer: CFO 3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia officer: SVP Gerneral Counsel 222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens director 1 IMATION WAY, OAKDALE MN 55128
Leah Jones officer: Chief Financial Officer 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan officer: President and CCO 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond officer: SVP & Chief HR Officer 305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison director 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey officer: Chief Client Delivery Officer 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko director
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley officer: SVP Gerneral Counsel & Corpora 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654

Veradigm (Veradigm) Headlines

From GuruFocus